Literature DB >> 29900990

Diagnostic Delay in Ankylosing Spondylitis: Related Factors and Prognostic Outcomes.

Sasan Fallahi1, Ahmad Reza Jamshidi2.   

Abstract

OBJECTIVES: This study aims to evaluate diagnostic delay, factors which are related to diagnostic delay, and the effect of diagnostic delay on prognostic outcomes in terms of spinal and hip mobility, functional status, disease activity, quality of life, cervical rotation, tragus to wall distance, and sacroiliitis severity in an Iranian population with ankylosing spondylitis (AS). PATIENTS AND METHODS: One hundred and sixty three patients (129 males, 34 females; mean age 37.74±9.88 years; range 18 to 65 years) with AS who met modified New York 1984 criteria were enrolled consecutively in a cross sectional survey. The main outcome variable (diagnostic delay) was defined as the interval between appearance of first symptoms and correct diagnosis of AS. Enthesitis, negative human leukocyte antigen B27 (HLA- B27), and educational level were among the factors of which their relationship to diagnostic delay were evaluated. The prognostic outcomes were measured using Bath ankylosing spondylitis functional index, Bath ankylosing spondylitis disease activity index, AS quality of life, Bath ankylosing spondylitis metrology index, chest expansion, and radiographic sacroiliitis severity.
RESULTS: Diagnostic delay was mean 7.88±7.17 years. Diagnostic delay was longer in patients with enthesitis (8.80±7.27) compared to patients without enthesitis (6.04±6.66) (p=0.007) and in HLA-B27 negative patients (10.10±7.44) compared to HLA-B27 positive patients (7.14±6.96) (p=0.013). Educational level was negatively correlated with diagnostic delay (p=0.002, r= -0.24). Diagnostic delay was correlated with Bath ankylosing spondylitis functional index (p=0.003, r=0.23), Bath ankylosing spondylitis disease activity index (p=0.026, r=0.18), AS quality of life (p=0.008, r=0.21), Bath ankylosing spondylitis metrology index (p<0.001, r=0.41), chest expansion (p<0.001, r= - 0.38), and sacroiliitis grading (p=0.042, r=0.16).
CONCLUSION: Negative HLA-B27, enthesitis, and low educational level are factors which affect diagnostic delay in AS. Individuals with enthesitis or low educational level should be evaluated accurately without causing delay in diagnosis since longer delay may lead to poorer prognostic outcomes.

Entities:  

Keywords:  Ankylosing spondylitis; delayed diagnosis; outcome; quality of life

Year:  2015        PMID: 29900990      PMCID: PMC5827863          DOI: 10.5606/ArchRheumatol.2016.5562

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  22 in total

1.  Effect of HLA-B*27 and its subtypes on clinical manifestations and severity of ankylosing spondylitis in Iranian patients.

Authors:  Sasan Fallahi; Mahdi Mahmoudi; Mohammad Hossein Nicknam; Farhad Gharibdoost; Elham Farhadi; Azad Saei; Keramat Nourijelyani; Nooshin Ahmadzadeh; Ahmad Reza Jamshidi
Journal:  Iran J Allergy Asthma Immunol       Date:  2013-08-28       Impact factor: 1.464

2.  Development of the ASQoL: a quality of life instrument specific to ankylosing spondylitis.

Authors:  L C Doward; A Spoorenberg; S A Cook; D Whalley; P S Helliwell; L J Kay; S P McKenna; A Tennant; D van der Heijde; M A Chamberlain
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

3.  Pattern of disease onset, diagnostic delay, and clinical features in juvenile onset and adult onset ankylosing spondylitis.

Authors:  Salih Ozgocmen; Ozge Ardicoglu; Ayhan Kamanli; Arzu Kaya; Bekir Durmus; Kadir Yildirim; Ozlem Baysal; Ali Gur; Saliha Karatay; Zuhal Altay; Remzi Cevik; Akin Erdal; Yuksel Ersoy; Aysegul J Sarac; Ibrahim Tekeoglu; Mahir Ugur; Kemal Nas; Kazim Senel; Hasan Ulusoy
Journal:  J Rheumatol       Date:  2009-11-02       Impact factor: 4.666

4.  Evaluation of the Iranian versions of the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Patient Acceptable Symptom State (PASS) in patients with ankylosing spondylitis.

Authors:  Katayoon Bidad; Sasan Fallahi; Mahdi Mahmoudi; Ahmadreza Jamshidi; Elham Farhadi; Alipasha Meysamie; Mohammad Hossein Nicknam
Journal:  Rheumatol Int       Date:  2011-11-20       Impact factor: 2.631

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  Relationship between diagnosis delay and disease features in Moroccan patients with ankylosing spondylitis.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Rachida Bensabbah; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2010-11-26       Impact factor: 2.631

7.  How to diagnose axial spondyloarthritis early.

Authors:  M Rudwaleit; D van der Heijde; M A Khan; J Braun; J Sieper
Journal:  Ann Rheum Dis       Date:  2004-05       Impact factor: 19.103

Review 8.  A systematic literature review of the economic impact of ankylosing spondylitis.

Authors:  Ilaria Palla; Leopoldo Trieste; Chiara Tani; Rosaria Talarico; Paolo A Cortesi; Marta Mosca; Giuseppe Turchetti
Journal:  Clin Exp Rheumatol       Date:  2012-10-16       Impact factor: 4.473

9.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

10.  Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria.

Authors:  Umit Dincer; Engin Cakar; M Zeki Kiralp; Hasan Dursun
Journal:  Clin Rheumatol       Date:  2007-09-26       Impact factor: 2.980

View more
  12 in total

1.  The journey of the non-radiographic axial spondyloarthritis patient: the perspective of professionals and patients.

Authors:  Teresa Otón; Carlos Sastre; Loreto Carmona
Journal:  Clin Rheumatol       Date:  2020-07-06       Impact factor: 2.980

2.  Interobserver reliability of Masei index validation by a multicenter collaborative group of rheumatologists.

Authors:  Patricia Moya Alvarado; Juan José de Agustín de Oro; María Aparicio Espinar; Eulàlia Armengol Pérez; Noemí Busquets Pérez; Loreto Carmona; Enrique Casado Burgos; Teresa Clavaguera Poch; Andrea Cuervo Aguilera; Eugenio De Miguel Mendieta; Paula Estrada Alarcón; Elisabet García Casares; Susana Holgado Pérez; Berta Magallares López; Melania Martinez Morillo; Lourdes Mateo Soria; Carmen Moragues Pastor; Mireia Moreno Martínez-Losa; Andrés Ponce Fernández; Manel Pujol Busquets; Julio Ramírez García; Delia Reina Sanz; Meritxell Sallés Lizarzaburu; Pilar Santo Panero; Elena Sirvent Alierta; Marta Valls Roc; Hèctor Corominas Macías
Journal:  Rheumatol Int       Date:  2020-11-04       Impact factor: 2.631

Review 3.  Expert recommendations on early diagnosis and referral of axial spondyloarthritis in the Kingdom of Saudi Arabia.

Authors:  Hanan Al Rayes; Mansour Alazmi; Khaled Alderaan; Mushabab Alghamdi; Nayef Alghanim; Ahmed Alhazmi; Nadeer Alkhadhrawi; Mohammad Almohideb; Zeyad Alzahrani; Mohamed Bedaiwi; Hussein Halabi; Suzan Attar
Journal:  Clin Rheumatol       Date:  2022-01-08       Impact factor: 2.980

Review 4.  Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review.

Authors:  Jobie Evans; Mark Sapsford; Scott McDonald; Kenneth Poole; Tim Raine; Deepak R Jadon
Journal:  Ther Adv Musculoskelet Dis       Date:  2021-03-11       Impact factor: 5.346

5.  Mechanism of Hip Arthropathy in Ankylosing Spondylitis: Abnormal Myeloperoxidase and Phagosome.

Authors:  Chaojie Yu; Xinli Zhan; Tuo Liang; Liyi Chen; Zide Zhang; Jie Jiang; Jiang Xue; Jiarui Chen; Chong Liu
Journal:  Front Immunol       Date:  2021-11-22       Impact factor: 7.561

6.  Alexithymia in ankylosing spondylitis.

Authors:  Deniz Karabıçak; Bilinç Doğruöz Karatekin; Afitap İçağasıoğlu
Journal:  Turk J Phys Med Rehabil       Date:  2021-09-01

Review 7.  Diagnostic delay in axial spondyloarthritis: a systematic review.

Authors:  Charles A Hay; Jon Packham; Sarah Ryan; Christian D Mallen; Alexandros Chatzixenitidis; James A Prior
Journal:  Clin Rheumatol       Date:  2022-02-19       Impact factor: 3.650

8.  Axial spondyloarthritis 10 years on: still looking for the lost tribe.

Authors:  Rosemarie Barnett; Thomas Ingram; Raj Sengupta
Journal:  Rheumatology (Oxford)       Date:  2020-10-01       Impact factor: 7.580

9.  Relation of therapies for ankylosing spondylitis and psoriatic arthritis to risk of myocardial infarction: a nested case control study.

Authors:  Rachael Stovall; Christine Peloquin; David Felson; Tuhina Neogi; Maureen Dubreuil
Journal:  BMC Rheumatol       Date:  2021-07-29

10.  Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis.

Authors:  Marco Garrido-Cumbrera; Victoria Navarro-Compán; Christine Bundy; Raj Mahapatra; Souzi Makri; José Correa-Fernández; Laura Christen; Carlos Jesús Delgado-Domínguez; Denis Poddubnyy
Journal:  Rheumatology (Oxford)       Date:  2022-02-02       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.